Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos M Ferrario

Showing results (11-20 of 239) with videos related to

Pageof 24
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 4, 2006
Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of researchCarlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|April 3, 2010
ARBITER 6-HALTS. Does it have the power to settle all matters?Carlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|March 21, 2009
MemorialCarlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Questions to ponderCarlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|January 16, 2009
Editorial: journal accomplishments in just one short yearCarlos M Ferrario
Current Opinion in Nephrology and Hypertension|November 4, 2010
ACE2: more of Ang-(1-7) or less Ang II?Carlos M Ferrario
The American Journal of the Medical Sciences|February 16, 2006
Highlights of the Twelfth Annual COSEHC National Scientific SessionCarlos M Ferrario
Diabetes & Metabolic Syndrome|August 7, 2020
Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"Carlos M Ferrario
Circulation|April 3, 2002
Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure?Carlos M Ferrario
Clinical Science (London, England : 1979)|March 2, 2021
Commentary on: Renin-angiotensin system overactivation in perivascular adipose tissue contributes to vascular dysfunction in heart failureCarlos M Ferrario
Pageof 24

Showing results (11-20 of 239) with videos related to

Sort By:
Pageof 24
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 4, 2006
Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of researchCarlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|April 3, 2010
ARBITER 6-HALTS. Does it have the power to settle all matters?Carlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|March 21, 2009
MemorialCarlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Questions to ponderCarlos M Ferrario
Therapeutic Advances in Cardiovascular Disease|January 16, 2009
Editorial: journal accomplishments in just one short yearCarlos M Ferrario
Current Opinion in Nephrology and Hypertension|November 4, 2010
ACE2: more of Ang-(1-7) or less Ang II?Carlos M Ferrario
The American Journal of the Medical Sciences|February 16, 2006
Highlights of the Twelfth Annual COSEHC National Scientific SessionCarlos M Ferrario
Diabetes & Metabolic Syndrome|August 7, 2020
Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic"Carlos M Ferrario
Circulation|April 3, 2002
Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure?Carlos M Ferrario
Clinical Science (London, England : 1979)|March 2, 2021
Commentary on: Renin-angiotensin system overactivation in perivascular adipose tissue contributes to vascular dysfunction in heart failureCarlos M Ferrario
Pageof 24